India, Dec. 1 -- The World Health Organisation on Monday conditionally recommended the use of GLP-1 therapies as part of long-term treatment for obesity, issuing its first guidelines on the same.

The first conditional recommendation made by WHO advises the use of GLP-1 drugs by adults, barring pregnant women, for long-term treatment of obesity. The second suggests pairing the drugs with a healthy diet and physical activity, Reuters reported.

The move comes even as the demand for the class of drugs known as GLP-1 agonists rose across the world, with governments trying to figure how to include these therapies in their public health systems.

The Glucagon-like peptide-1 receptor agonists, or GLP-1s, are a type of medicine administered to p...